Development of blood-based biomarkers, diagnostic kit development and commercialization for early diagnosis of dementia.
Acquisition of source technology to identify and control the interaction between brain and
peripheral immune system and Alzheimer's disease.
Identification of the mechanism of gut-brain interaction and development of the source technology to control the intestinal environment.
Establishment of individual stem cell and organoid banks for personalized medical care, and development of personalized drug efficiency screening technology